You've done everything "right" according to conven
Importing anamorelin's clinical dataset to Ipamorelin claims is methodologically inappropriate: the molecules differ in chemistry (pentapeptide versus small molecule), route (subcutaneous versus oral), and indication
So the peptide is not just present it is active in processes people actually care about when they are trying to look better, heal better, or age a little less visibly
COA / Lab results Evidence: Preclinical Pros Studied for tendon, ligament, muscle and bone repair Angiogenic and gut-protective action in animal models Stable in gastric juice, unlike many growth-factor peptides Commonly paired with TB-500 in recovery protocols Cons Evidence is preclinical animal/in-vitro only, no human trials Human efficacy and dosing unestablished Pros and cons summarise available published data from peer-reviewed studies
The L-Carnitine is also marketed in another form: acetyl L-Carnitine
324 CD38 also exerts bactericidal activity in an NAD + -dependent manner